Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: KHS who wrote (19289)	3/6/1999 11:41:00 PM
From: VLAD	Respond to of 23519

KHS, I paid $5.00 today to get an S&P Stock Report on Vivus dated March 4th. Looking at some of the tables/graphs of the high/low prices of Vivus in 1994, 1995 and 1996 gave me a good laugh. Vivus traded above 20 before they even knew if they would get MUSE FDA approved. It traded above 15 as early as 1995 and the company didn't sell a single unit of MUSE until 1997. Now here we are 2 years later and we know that we have a proven safe and effective non-needle treatment for ED and the stock is treated like it has the plague. VLAD PS A friend of mine recently had a long conversation with the new CFO. He seems to be a shrewd guy and really believes he can turn things around for Vivus in more ways than one. I hate the share price but I believe your mention of 1997 stock prices is not too far fetched. Don't forget that gap down from 21 to 15--it bothers the best of technicians and still needs to be filled.